Characterisation of patient-derived site-specific in vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging
Characterisation of patient-derived site-specific in vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging
Background: there is an urgent need for novel targeted therapeutic strategies for pediatric-type diffuse high-grade glioma (PDHGG) to improve patient outcomes, the development of which demands model systems that accurately recapitulate the specific PDHGG subtypes. Characterization, longitudinal monitoring and, ultimately, evaluation of treatment response in these models requires sensitive non-invasive imaging techniques such as magnetic resonance imaging (MRI).
Methods: thirty-five patient-derived, site-specific, orthotopic in vivo models of PDHGG, established using implantation of patient tumor material or patient-derived in vitro cultures maintained in stem cell retaining conditions, were characterized using multiparametric MRI.
Results: median survival ranged from 54 to 433 days. Tumors identified on T2-weighted (T2w) images varied in appearance from a diffuse hyperintense signal to well-defined high contrast masses, and distribution of human nuclear antigen positive tumor cells corresponded to regions of T2w signal hyperintensity. Apparent diffusion coefficient was significantly higher in brainstem diffuse midline glioma (DMG) models than in diffuse hemispheric glioma (DHG) tumors, mirroring clinical observations. Lack of contrast-agent enhancement indicated an intact blood-brain barrier in most models, with heterogeneous disruption observed in four DHG models. Upon re-implantation, survival was significantly shortened in 3/4 DHG tumors and 1/10 DMG models, while quantitative MRI parameters remained similar. Furthermore, when 3 models grown in 2D and 3D in vitro were implanted in parallel, poorer survival or improved penetrance was associated with 3D cultures.
Conclusion: we established a comprehensive pre-clinical platform in which to evaluate the efficacy of therapeutic strategies against PDHGG in vivo, enhanced by the use of multiparametric MRI.
magnetic resonance imaging, orthotopic xenografts, pediatric-type diffuse high-grade glioma, pre-clinical models
Boult, Jessica K.R.
280c6d04-0161-49ff-b27a-30413f60b929
Gray, Juliet
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
27 February 2026
Boult, Jessica K.R.
280c6d04-0161-49ff-b27a-30413f60b929
Gray, Juliet
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
Boult, Jessica K.R., Carvalho, Diana M. and Kessler, Ketty
,
et al.
(2026)
Characterisation of patient-derived site-specific in vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging.
Neuro-Oncology Advances, 8 (1), [vdag049].
(doi:10.1093/noajnl/vdag049).
Abstract
Background: there is an urgent need for novel targeted therapeutic strategies for pediatric-type diffuse high-grade glioma (PDHGG) to improve patient outcomes, the development of which demands model systems that accurately recapitulate the specific PDHGG subtypes. Characterization, longitudinal monitoring and, ultimately, evaluation of treatment response in these models requires sensitive non-invasive imaging techniques such as magnetic resonance imaging (MRI).
Methods: thirty-five patient-derived, site-specific, orthotopic in vivo models of PDHGG, established using implantation of patient tumor material or patient-derived in vitro cultures maintained in stem cell retaining conditions, were characterized using multiparametric MRI.
Results: median survival ranged from 54 to 433 days. Tumors identified on T2-weighted (T2w) images varied in appearance from a diffuse hyperintense signal to well-defined high contrast masses, and distribution of human nuclear antigen positive tumor cells corresponded to regions of T2w signal hyperintensity. Apparent diffusion coefficient was significantly higher in brainstem diffuse midline glioma (DMG) models than in diffuse hemispheric glioma (DHG) tumors, mirroring clinical observations. Lack of contrast-agent enhancement indicated an intact blood-brain barrier in most models, with heterogeneous disruption observed in four DHG models. Upon re-implantation, survival was significantly shortened in 3/4 DHG tumors and 1/10 DMG models, while quantitative MRI parameters remained similar. Furthermore, when 3 models grown in 2D and 3D in vitro were implanted in parallel, poorer survival or improved penetrance was associated with 3D cultures.
Conclusion: we established a comprehensive pre-clinical platform in which to evaluate the efficacy of therapeutic strategies against PDHGG in vivo, enhanced by the use of multiparametric MRI.
This record has no associated files available for download.
More information
Accepted/In Press date: 24 February 2026
e-pub ahead of print date: 27 February 2026
Published date: 27 February 2026
Keywords:
magnetic resonance imaging, orthotopic xenografts, pediatric-type diffuse high-grade glioma, pre-clinical models
Identifiers
Local EPrints ID: 510780
URI: http://eprints.soton.ac.uk/id/eprint/510780
ISSN: 2632-2498
PURE UUID: a60c691e-8eb9-4a62-8273-c616647842da
Catalogue record
Date deposited: 21 Apr 2026 16:59
Last modified: 22 Apr 2026 01:39
Export record
Altmetrics
Contributors
Author:
Jessica K.R. Boult
Author:
Diana M. Carvalho
Author:
Ketty Kessler
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
